AV
Aveanna Healthcare Holdings Inc.
AVAH · NASDAQ
$12.78 +1.27% (+$0.16)
1M -5.44%
Market Cap $2.93B
P/E Ratio 10.65x
Div. Yield -
ROE 150.20%
Bulios Fair Price
$8.78
31.3% downside
Current Price
$12.78
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVAH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
68 /100
Cheap EV/EBITDA 14.49x
P/S 1.12x
P/B 10.19x
Growth
70 /100
Growing Rev. growth 10.82%
FCF growth N/A
Book val. growth N/A
Profitability
53 /100
Moderate Net margin 10.56%
Op. margin 11.12%
FCF margin 6.37%
Quality
100 /100
Excellent ROE 150.20%
ROA 13.04%
Asset turnover 1.24x
Debt
17 /100
High Current ratio 1.16x
Int. coverage 2.24x
Net debt/EBITDA 4.71x
Stability
33 /100
Unstable Rev. volatility 7.96%
EPS volatility 1,077.23%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVAH
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Jeffrey S. Shaner
Employees
35,500
Headquarters
Atlanta
Upcoming events
05 NOV
Earnings
Upcoming earnings report